Literature DB >> 18397982

Adiponectin and left ventricular structure and function in healthy adults.

Michaela Kozakova1, Elza Muscelli, Allan Flyvbjerg, Jan Frystyk, Carmela Morizzo, Carlo Palombo, Ele Ferrannini.   

Abstract

CONTEXT: Adiponectin inhibits protein synthesis in cardiac myocytes, thereby opposing the effect of cardiac workload and trophic factors (in particular, insulin) on left ventricular (LV) mass and wall thickness (WT).
OBJECTIVE: We tested whether adiponectin and its isoforms are related to LV mass, WT, and function independently of metabolic factors.
DESIGN: This was a cross-sectional study.
SUBJECTS: The study included 77 healthy volunteers (42 men) aged 30-59 yr with normal LV structure and function. MAIN OUTCOME MEASURES: Insulin response and insulin sensitivity were assessed by oral glucose tolerance test and euglycemic hyperinsulinemic clamp. LV mass, WT, stroke work, chamber function, and myocardial longitudinal function were evaluated by standard Doppler echocardiography and tissue Doppler imaging. Total and molecular isoforms of adiponectin were measured in plasma.
RESULTS: By multivariate analysis, independent factors affecting LV mass were sex, body mass index, stroke work, and current smoking (R(2) = 0.66). Independent correlates of LV WT were age, stroke work, and plasma adiponectin (standardized r = 0.28, 0.41, and -0.26, P at least < 0.005, R(2) = 0.48). LV longitudinal late diastolic velocity was independently related to age, body mass index, and adiponectin (standardized r = 0.20, 0.26, -0.33, P at least < 0.05, R(2) = 0.30). High-molecular-weight adiponectin (47% of total), but not lower molecular-weight isoforms, insulin sensitivity, or other metabolic factors, was inversely and independently related to WT (standardized r = -0.27, P < 0.01) and myocardial longitudinal late diastolic velocity (standardized r = -0.28, P < 0.05).
CONCLUSION: In healthy subjects, circulating total and high-molecular-weight adiponectin are related to LV WT and diastolic function, independently of age and metabolic factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397982     DOI: 10.1210/jc.2007-2580

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Bariatric surgery to unload the stressed heart: a metabolic hypothesis.

Authors:  Mohamed F Algahim; Shiraj Sen; Heinrich Taegtmeyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

2.  Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study.

Authors:  David D McManus; Asya Lyass; Erik Ingelsson; Joseph M Massaro; James B Meigs; Jayashri Aragam; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Obesity (Silver Spring)       Date:  2011-02-24       Impact factor: 5.002

3.  Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease.

Authors:  Ken Shinmura
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 4.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

Review 5.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Association of adiponectin with left ventricular mass in blacks: the Jackson Heart Study.

Authors:  Aurelian Bidulescu; Jiankang Liu; Solomon K Musani; Ervin R Fox; Tandaw E Samdarshi; Daniel F Sarpong; Viola Vaccarino; Peter W Wilson; Donna K Arnett; Rebecca Din-Dzietham; Herman A Taylor; Gary H Gibbons
Journal:  Circ Heart Fail       Date:  2011-08-12       Impact factor: 8.790

7.  Obesity and preclinical changes of cardiac geometry and function.

Authors:  Joong Kyung Sung; Jang-Young Kim
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

8.  Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy.

Authors:  Tiziana Di Chiara; Christiano Argano; Alessandra Scaglione; Giovanni Duro; Salvatore Corrao; Rosario Scaglione; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2014-07-18       Impact factor: 3.397

9.  Association of serum adiponectin and insulin-like growth factor I levels with parameters of cardiac remodeling in severely obese patients.

Authors:  A Sirbu; I Stanca; C Copaescu; S Martin; A Albu; C Barbu; S Fica
Journal:  J Endocrinol Invest       Date:  2013-04-02       Impact factor: 4.256

10.  Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study).

Authors:  Maria G Karas; David Benkeser; Alice M Arnold; Traci M Bartz; Luc Djousse; Kenneth J Mukamal; Joachim H Ix; Susan J Zieman; David S Siscovick; Russell P Tracy; Christos S Mantzoros; John S Gottdiener; Christopher R deFilippi; Jorge R Kizer
Journal:  Am J Cardiol       Date:  2013-10-03       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.